When did PRESTIGE CONSUMER HEALTHCARE (PBH) report earnings last quarter?
PRESTIGE CONSUMER HEALTHCARE (PBH) last reported earnings on 2/5/2026.
PRESTIGE CONSUMER HEALTHCARE (PBH) Earnings History & Surprises
NYSE:PBH • US74112D1019
Current stock price
57.73 USD
+0.16 (+0.28%)
Last:
PBH Earnings overview
Past quarterly earnings results for PRESTIGE CONSUMER HEALTHCARE (PBH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 30, 2026
- Period
- Q4 / 2026
- EPS Estimate
- $1.40
- Revenue Estimate
- 297.67M
Last Reported
Most Recent- Release Date
- Feb 5, 2026
- Period
- Q3 / 2026
- EPS Reported
- $1.14
- EPS Surprise
- -1.36%
- Revenue Surprise
- -0.49%
Beat Rate
Last 8 Quarters 50%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | 1.14 | 1.16 | -1.36% | -6.56% | 283.44M | 284.83M | -0.49% | -2.37% |
| Q2 2026 | 1.07 | 0.98 | 9.18% | -1.83% | 274.114M | 259.7M | 5.55% | -3.41% |
| Q1 2026 | 0.95 | 1.01 | -5.96% | 5.56% | 249.53M | 263.62M | -5.34% | -6.59% |
| Q4 2025 | 1.32 | 1.31 | 0.64% | 34.69% | 296.518M | 292.25M | 1.46% | 7.05% |
| Q3 2025 | 1.22 | 1.17 | 4.30% | 15.09% | 290.317M | 289.35M | 0.33% | 2.68% |
| Q2 2025 | 1.09 | 1.10 | -0.47% | 1.87% | 283.785M | 284.91M | -0.39% | -0.88% |
| Q1 2025 | 0.90 | 0.87 | 3.55% | -15.09% | 267.142M | 263.02M | 1.57% | -4.36% |
| Q4 2024 | 0.98 | 1.15 | -14.94% | 120.29% | 276.991M | 290.34M | -4.60% | -3.11% |
| Q3 2024 | 1.06 | 1.05 | 0.80% | 1.92% | 282.741M | 283.05M | -0.11% | 2.62% |
| Q2 2024 | 1.07 | 1.08 | -0.65% | 4.90% | 286.316M | 288.06M | -0.61% | -1.02% |
| Q1 2024 | 1.06 | 1.02 | 3.95% | -2.75% | 279.309M | 281.58M | -0.81% | 0.81% |
| Q4 2023 | -4.83 | 1.05 | -559.82% | -630.77% | 285.869M | 281.79M | 1.45% | 7.09% |
| Q3 2023 | 1.04 | 1.02 | 1.62% | 5.05% | 275.524M | 276.46M | -0.34% | 0.38% |
| Q2 2023 | 1.02 | 1.01 | 0.81% | - | 289.273M | 286.02M | 1.14% | 4.72% |
| Q1 2023 | 1.09 | 1.05 | 3.95% | -4.39% | 277.059M | 271.62M | 2.00% | 2.93% |
| Q4 2022 | 0.91 | 0.90 | 1.62% | 15.19% | 266.936M | 260.82M | 2.34% | 12.25% |
| Q3 2022 | 0.99 | 0.89 | 10.97% | 22.22% | 274.47M | 262.99M | 4.37% | 14.94% |
| Q2 2022 | 1.02 | 1.00 | 2.35% | 30.77% | 276.225M | 263.81M | 4.71% | 16.35% |
| Q1 2022 | 1.14 | 0.88 | 30.24% | 32.56% | 269.181M | 234.74M | 14.67% | 17.34% |
| Q4 2021 | 0.79 | 0.79 | 0.26% | -3.66% | 237.8M | 232.69M | 2.20% | -5.33% |
| Q3 2021 | 0.81 | 0.77 | 4.58% | - | 238.8M | 233.8M | 2.14% | -1.16% |
| Q2 2021 | 0.78 | 0.72 | 7.69% | 14.71% | 237.4M | 229.7M | 3.35% | -0.29% |
| Q1 2021 | 0.86 | 0.71 | 21.73% | 32.31% | 229.4M | 223.53M | 2.63% | -1.21% |
| Q4 2020 | 0.82 | 0.74 | 10.13% | - | 251.2M | 242.24M | 3.70% | - |
| Q3 2020 | 0.81 | 0.76 | 6.22% | - | 241.6M | 242.85M | -0.51% | - |
| Q2 2020 | 0.68 | 0.66 | 2.63% | - | 238.1M | 239.55M | -0.61% | - |
| Q1 2020 | 0.65 | 0.64 | 1.13% | - | 232.2M | 233.85M | -0.71% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
0.63%
Max EPS beat (4)
9.18%
Min EPS beat (4)
-5.96%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
0.29%
Max Revenue beat (4)
5.55%
Min Revenue beat (4)
-5.34%
Analysis
In the last 4 quarters, PBH has beaten EPS estimates in 2 out of 4 releases
PBH has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, PBH has beaten the EPS estimates by 0.6% on average.
In the last 4 quarters, PBH has beaten the revenue estimates by 0.3% on average.
Related analysis
PRESTIGE CONSUMER HEALTHCARE / PBH Earnings FAQ
Can you provide information on whether PRESTIGE CONSUMER HEALTHCARE beat earnings estimates in the last quarter?
PRESTIGE CONSUMER HEALTHCARE (PBH) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often PRESTIGE CONSUMER HEALTHCARE beats earnings estimates?
In the last 4 quarters, PRESTIGE CONSUMER HEALTHCARE (PBH) has beaten EPS estimates in 2 out of 4 releases.